Inflammasome Therapeutics is focused on developing therapies for degenerative diseases such as Alzheimer’s disease, multiple sclerosis, macular degeneration, and Parkinson's disease.

By focusing on Inflammasome activation, we are working to treat these diseases through a new, innovative approach.

Explore Our Approach



For inquiries about our clinical trials and treatments, please reach out.

Contact Us